Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
CURRENT ASSETS:
Cash and cash equivalents	$ 13,128	$ 13,116
Accounts receivable, net of allowance for doubtful accounts of $2,858 and $2,650 at 2019 and 2018, respectively	137,355	129,157
Inventories	53,528	45,664
Prepaid expenses	12,508	15,351
Income taxes receivable	7,853	13,993
Other current assets	6,314	13,696
TOTAL CURRENT ASSETS	230,686	230,977
PROPERTY, PLANT AND EQUIPMENT, net	125,078	122,917
RIGHT OF USE ASSETS	76,238
INTANGIBLES, net	17,763	13,054
GOODWILL	213,425	219,412
DEFERRED TAX ASSETS, net	71,296	11,252
OTHER ASSETS	53,210	51,215
TOTAL ASSETS	787,696	648,827
CURRENT LIABILITIES:
Accounts payable	42,191	41,155
Accrued payroll and related costs	27,866	22,549
Taxes other than payroll and income	7,961	7,488
Unearned revenues	12,348	17,325
Operating lease liabilities	11,869
Income taxes payable	4,996	2,917
Other current liabilities	12,766	11,113
TOTAL CURRENT LIABILITIES	119,997	102,547
LONG-TERM DEBT, net	297,148	289,770
LONG-TERM OPERATING LEASE LIABILITIES	63,754
DEFERRED COMPENSATION	49,072	49,359
DEFERRED TAX LIABILITIES, net	29,196	7,634
OTHER LONG-TERM LIABILITIES	33,968	38,617
COMMITMENTS AND CONTINGENCIES
EQUITY:
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	0	0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 44,796,252 issued and 44,374,852 outstanding at 2019 and 44,796,252 issued and 44,316,845 outstanding at 2018	1,148	1,148
Additional paid-in capital	64,498	57,438
Retained earnings	174,615	156,130
Accumulated other comprehensive income (loss)	(6,604)	(5,456)
Treasury shares (at cost), 421,400 at 2019 and 479,407 at 2018	(43,411)	(52,501)
Total Core Laboratories N.V. shareholders' equity	190,246	156,759
Non-controlling interest	4,315	4,141
TOTAL EQUITY	194,561	160,900
TOTAL LIABILITIES AND EQUITY	$ 787,696	$ 648,827